Mortality in epilepsy
Searching for clues in populations and patients
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In this issue of Neurology, two groups using complementary methods report findings relevant to mortality in epilepsy. In one study, Strauss et al.1 used a population-based approach to further refine our understanding of epilepsy’s effect per se on mortality by applying person-time methodology in a population of California residents with mild developmental disabilities. In the other study, Tigaran et al.2 used a patient-based approach, performing extensive cardiovascular examinations on a small cohort of individuals with refractory epilepsy. This latter group’s goal was to identify a mechanism for sudden unexplained death in epilepsy (SUDEP) in this high-risk population. Both approaches contribute to understanding excess mortality in epilepsy overall and SUDEP specifically.
Within the cohort of California residents with mild developmental disabilities, Strauss et al.1 estimated epilepsy’s impact on this population’s mortality rate by comparing the mortality rate of patients with a history of epilepsy with the mortality rate of patients with no history of epilepsy. A strength of their approach was that person-time was used as the unit of study. Thus, if a patient shifted from actively having seizures to having only a remote history of seizures during his period of participation in the cohort, the time he contributed to the cohort could be allotted to each …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
Causes of death in remote symptomatic epilepsyS. M. Day, Y. W. Wu, D. J. Strauss et al.Neurology, July 25, 2005 -
Articles
Population-based study of the incidence of sudden unexplained death in epilepsyD. M. Ficker, E. L. So, W. K. Shen et al.Neurology, November 01, 1998 -
Articles
Remote symptomatic epilepsyDoes seizure severity increase mortality?David J. Strauss, Steven M. Day, Robert M. Shavelle et al.Neurology, February 11, 2003 -
Article
Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsyDileep R. Nair, Kenneth D. Laxer, Peter B. Weber et al.Neurology, July 20, 2020